Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Survival Tree01:19

Survival Tree

172
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
172
Genetic Screens02:46

Genetic Screens

5.1K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.1K
Cancer Survival Analysis01:21

Cancer Survival Analysis

472
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
472
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

337
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
337
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

323
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
323

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A systematically optimized two-dose differential strategy integrating stable isotope tracing and mass shift defect filtering for reducing false positives in high-resolution mass spectrometry-based drug metabolite profiling.

Talanta·2026
Same author

Effect of Extended Dual Antiplatelet Therapy on the Prognosis of Patients With ST Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Retrospective Cohort Study.

Health science reports·2026
Same author

Robust Cancer Biomarker Identification From Matched Transcriptomic Data Via Bootstrapped Regularized Conditional Logistic Regression.

Cancer informatics·2025
Same author

Cancer classification and functional pathway discovery using TCGA transcriptomic profiles: A matched case-control framework.

Journal of bioinformatics and computational biology·2025
Same author

Multicategory Survival Outcomes Classification via Overlapping Group Screening Process Based on Multinomial Logistic Regression Model With Application to TCGA Transcriptomic Data.

Cancer informatics·2024
Same author

Photoinduction of Ferroptosis and cGAS-STING Activation by a H<sub>2</sub>S-Responsive Iridium(III) Complex for Cancer-Specific Therapy.

Journal of medicinal chemistry·2024

Related Experiment Video

Updated: Sep 30, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.3K

Feature screening for survival trait with application to TCGA high-dimensional genomic data.

Jie-Huei Wang1, Cai-Rong Li1, Po-Lin Hou1

  • 1Department of Statistics, Feng Chia University, Taichung, Taiwan.

Peerj
|March 16, 2022
PubMed
Summary

Network-adjusted feature screening effectively identifies cancer-related genes from high-dimensional genomic data, improving survival prediction accuracy. This bioinformatics approach outperforms existing methods by considering gene-gene dependencies.

Keywords:
Breast invasive carcinomaEsophageal cancerHead and neck squamous cell carcinomaHigh-dimensional genomic dataLung adenocarcinomaNetworkPancreatic cancerSurvival feature screeningSurvival predictionTCGA

More Related Videos

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.7K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.1K

Related Experiment Videos

Last Updated: Sep 30, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.3K
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.7K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.1K

Area of Science:

  • Bioinformatics and Computational Biology
  • Genomics and Cancer Research
  • Biostatistics and Survival Analysis

Background:

  • Identifying cancer-related genes in high-dimensional survival genomic data is crucial but challenging.
  • Numerous feature screening methods exist, but systematic comparisons are lacking.
  • Existing methods often overlook gene-gene dependency information.

Purpose of the Study:

  • To systematically compare existing feature screening methods through simulation studies.
  • To develop a more accurate patient survival prediction model using The Cancer Genome Atlas (TCGA) datasets.
  • To evaluate a novel network-adjusted feature screening approach.

Main Methods:

  • Conducted simulation studies to compare feature screening methods.
  • Applied network-adjusted feature screening to TCGA survival genomic data.
  • Utilized gene-gene dependency information in the proposed method.

Main Results:

  • Network-adjusted feature screening demonstrated superior performance compared to univariate independent feature screening methods.
  • The proposed approach achieved more accurate survival prediction by incorporating gene-gene dependency.
  • Identified cancer-related genes and biomarkers for esophageal, pancreatic, head and neck, lung, and breast cancers.

Conclusions:

  • The network-adjusted feature selection method offers significant advantages over methods that ignore gene-gene dependencies.
  • The network-based screening method is reliable and credible for identifying cancer-related genes.
  • This approach enhances the accuracy of survival prediction models in cancer genomics.